Wells Fargo & Company Organigram Holdings Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.92 - $1.81 $328 - $646	-357 Reduced 87.71%	50 $0
Q1 2022 May 16, 2022	BUY	$1.3 - $1.83 $189 - $267	146 Added 55.94%	407 $0
Q3 2021 Nov 15, 2021	SELL	$2.3 - $2.94 $223 - $285	-97 Reduced 27.09%	261 $0
Q2 2021 Aug 16, 2021	BUY	$2.34 - $3.49 $343 - $513	147 Added 69.67%	358 $1,000
Q4 2020 Feb 09, 2021	SELL	$1.03 - $1.65 $691 - $1,107	-671 Reduced 76.08%	211 $0
Q3 2020 Nov 05, 2020	SELL	$1.01 - $1.62 $18 - $29	-18 Reduced 2.0%	882 $1,000
Q2 2020 Aug 13, 2020	BUY	$1.17 - $2.18 $819 - $1,526	700 Added 350.0%	900 $1,000
Q1 2020 May 14, 2020	BUY	$1.44 - $3.4 $288 - $680	200 New	200 $0

7.38M

Ticker OGI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 313,708,000
Market Cap $461M
Description
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.